Australian (ASX) Stock Market Forum

IMM - Immutep Limited

Jump to new
Wysiwyg said:
Bit of a false break of resistance. Sometimes these pullbacks are privileged information driven but if so we won't know until it comes out.
Click to expand...

Finally read the investor update this morning, March & July.

Rather conspicuous how no mention is made of the NASDAQ listing in the July update.

It was all over the front page of the March edition. " We are also preparing for the Company's listing on the NASDAQ ... and we look forward to being able to confirm a listing date in the near future."

I'd say people are tired of waiting, esp with the weakness in the general market.
 
grandia3 said:
hmmm a morning star pattern?
interesting

I am holding and waiting for tomorrow as well :)
Click to expand...
:mad: it didn't hold that pattern; do we get another chance today?

PRR am 03-06-11.gif
I'm taking a chance - on the assumption that the world isn't going to end anytime soon and a bounce might even come as early as tomorrow or Friday. :cool:
 
Gee whiz. Copping a flogging today as the sentiment rises to out at any price. Is Slipperz any the wiser here on the rush to the door?
 
well, thought that I will post a point regarding DNDN (our sibling? since PRR is often compared with DNDN)
it dips to $11 in the after hour trade
18:15 $ 13 100
18:14 $ 11 201,900
17:08 $ 35.2849 2,600
16:48 $ 35.2849 200
16:48 $ 35.2849 100

oh well, who is that who dumps ~$2m at 18:14?
I just cannot think of any logical reason to dump it at $11 seeing the previous trade is still $35 :confused:
 
grandia3 said:
well, thought that I will post a point regarding DNDN (our sibling? since PRR is often compared with DNDN)
it dips to $11 in the after hour trade
18:15 $ 13 100
18:14 $ 11 201,900
17:08 $ 35.2849 2,600
16:48 $ 35.2849 200
16:48 $ 35.2849 100

oh well, who is that who dumps ~$2m at 18:14?
I just cannot think of any logical reason to dump it at $11 seeing the previous trade is still $35 :confused:
Click to expand...

Dendreon Corporation
(NasdaqGS: DNDN )

Real Time 12.93 Down 22.91 (63.92%) 23:50

This is looking really REALLY BAD atm. If that is anything to go by......
 
Also "Australian health care company Prima BioMed (Prima) (ASX: PRR) is pleased to announce that the Staatsministerium für Wissenschaft und Kunst (the State Ministry for Higher Education, Research and the Arts or SMWK) of the Free State of Saxony, Germany, has granted a EUR 4.1 million award to fund parts of the CVac™ clinical program in Europe". :)
 
Some nice action on this stock this arvo, may be a bit of resistance around 19.5 to 20c but overcoming a negative market after todays news.

A close at or above yesterdays at 19.5 would be a good sign.
 
Tomorrow will be a bit of a litmus test. A 4.1million dollar grant is great for the company and the news was pretty well timed!

The massive hit that shook DNDN this week is really good for us in the sense that the problems to a commercial roll out are being realised and hopefully we won't make the same mistakes.

Perhaps the initial guidance for Provenge sales was overly optimistic. It is now obvious when a treatment costs 93K doctors aren't going to be keen to pay up front for the cost and then they need to be trained in it's usage as well.

Anyhoo soon we will have our sales going forward in Dubai while the trials continue ( only a quarter or so until revenues start there) and they are also mentioning it's use to fight other mucin-1 overexpressing cancers such as breast cancer also.

The cautionary provenge tale might deter some more speculatative Nasdaq investors when (if????) we eventually list in the US but from a long term perspective this weeks trading action will look like a minor blip in a couple of years.

Holding long and strong :)
 
Slipperz said:
Holding long and strong :)
Click to expand...

Amen to that (=. It takes a lot of courage though, in a market like this, NO ONE has time for a speccy biotech stock that is our Prima. I'm pretty sure it's going to get a LOT worse before it gets better, so I'm gonna stash away my PRR shares till 2018 when they're worth $4 each post FDA approval =).
 
isplicer said:
Amen to that (=. It takes a lot of courage though, in a market like this, NO ONE has time for a speccy biotech stock that is our Prima. I'm pretty sure it's going to get a LOT worse before it gets better, so I'm gonna stash away my PRR shares till 2018 when they're worth $4 each post FDA approval =).
Click to expand...

I'm in the same boat as you guys. got my shares at 25c a pop. Time to buckle down and ride it out!
 
Slipperz said:
Been looking at the Fraunhofer site and they are pretty big potatoes in euroland. http://www.fraunhofer.de/en/about-fraunhofer/

Our association with them is very positive for the future with regard to approval from the EU regulatory authorities.

Nice they gave us 4 million as well! :)
Click to expand...

Out of curiosity, what effect would this 4 million euro grant have on share price? I mean at the moment, market sentiment is down and this bit of news came out on Friday already, which should have been priced in already.

So by Monday there should be almost no significant change (Well in theory! Whatever happens on Monday is a diff game!)
 
What happens on monday is absolutely unbeknownst to anyone. I'm just worried about the Phase IIb results getting released.

It shocks me to see the number of people not caring at all about these crucial, crucial milestones for PRR and focusing on market sentiment instead. Eyes on the prize, guys! A worldwide collapse won't worry me one bit - Women will (most unfortunately) keep getting Ovarian cancer and someone needs to find a cure; the demand will ALWAYS be there. If the SP falls, so be it - we are in pure speculation mode developing our product and I don't blame the market - After all, we have no revenue.

What WILL terrify me, however, are results actually relating to CVac. If it so happens that trial results are delayed, knocked back or unsatisfactory, that is when I'll throw my hands up and admit we're screwed. Until then, CVac seems to be doing absolutely fine - what more could you ask for at this stage? Approval in Dubai, media exposure in Australia, encouraging results in Phase IIa, SPP oversubscription, funding from Germany. All signs point to the damn thing working. We're cashed up and ready to go. The journey continues for PRR.

If Mr. Rogers can take us on this journey for the next six years the same way we have so far, we will have an explosion of revenue given the manufacturing process is scaled well (perhaps even before the FDA approves Cvac). We're set for worldwide penetration - Europe, US, Australia and now the middle east. To top it off, we can learn from DNDN, where they've failed in accounting/rolling out the immunotherapy across practices, we can succeed. For those who believe, stop pressing F5, wake up on one fine morning in 2019 and put in a sell order for $5.50 =).
 
isplicer said:
What happens on monday is absolutely unbeknownst to anyone. I'm just worried about the Phase IIb results getting released.

It shocks me to see the number of people not caring at all about these crucial, crucial milestones for PRR and focusing on market sentiment instead. Eyes on the prize, guys! A worldwide collapse won't worry me one bit - Women will (most unfortunately) keep getting Ovarian cancer and someone needs to find a cure; the demand will ALWAYS be there. If the SP falls, so be it - we are in pure speculation mode developing our product and I don't blame the market - After all, we have no revenue.

What WILL terrify me, however, are results actually relating to CVac. If it so happens that trial results are delayed, knocked back or unsatisfactory, that is when I'll throw my hands up and admit we're screwed. Until then, CVac seems to be doing absolutely fine - what more could you ask for at this stage? Approval in Dubai, media exposure in Australia, encouraging results in Phase IIa, SPP oversubscription, funding from Germany. All signs point to the damn thing working. We're cashed up and ready to go. The journey continues for PRR.

If Mr. Rogers can take us on this journey for the next six years the same way we have so far, we will have an explosion of revenue given the manufacturing process is scaled well (perhaps even before the FDA approves Cvac). We're set for worldwide penetration - Europe, US, Australia and now the middle east. To top it off, we can learn from DNDN, where they've failed in accounting/rolling out the immunotherapy across practices, we can succeed. For those who believe, stop pressing F5, wake up on one fine morning in 2019 and put in a sell order for $5.50 =).
Click to expand...

@ Isplicer. You sir are a fantastic salesman. I salute you. ALRIGHT! Let's go in. 2019 here we come!!!
 
market sentiment seems to be the driving factor in pushing PRR down. I considered buying the placement at 28 cents, (but lack of funds stopped me!) I thought I had missed the boat but the current price is more than inviting.
 
Top